Del Conte, A.; De Carlo, E.; Bertoli, E.; Stanzione, B.; Revelant, A.; Bertola, M.; Spina, M.; Bearz, A.
Bone Metastasis and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC): Microenvironment and Possible Clinical Implications. Int. J. Mol. Sci. 2022, 23, 6832.
https://doi.org/10.3390/ijms23126832
AMA Style
Del Conte A, De Carlo E, Bertoli E, Stanzione B, Revelant A, Bertola M, Spina M, Bearz A.
Bone Metastasis and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC): Microenvironment and Possible Clinical Implications. International Journal of Molecular Sciences. 2022; 23(12):6832.
https://doi.org/10.3390/ijms23126832
Chicago/Turabian Style
Del Conte, Alessandro, Elisa De Carlo, Elisa Bertoli, Brigida Stanzione, Alberto Revelant, Manuela Bertola, Michele Spina, and Alessandra Bearz.
2022. "Bone Metastasis and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC): Microenvironment and Possible Clinical Implications" International Journal of Molecular Sciences 23, no. 12: 6832.
https://doi.org/10.3390/ijms23126832
APA Style
Del Conte, A., De Carlo, E., Bertoli, E., Stanzione, B., Revelant, A., Bertola, M., Spina, M., & Bearz, A.
(2022). Bone Metastasis and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC): Microenvironment and Possible Clinical Implications. International Journal of Molecular Sciences, 23(12), 6832.
https://doi.org/10.3390/ijms23126832
